REQUEST A DEMO
Total
USD $0.00
Search more companies

Consun Pharmaceutical Group Limited (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Consun Pharmaceutical Group Limited Profile Updated: March 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

The company is an integrated pharmaceutical company principally engaged in the research, manufacturing and sale of modern Chinese medicines and medical contrast medium in the PRC.

Headquarters
22Nd Floor, World-Wide House, 19 Des Voeux Road
Hong Kong; Hong Kong;

Contact Details: Purchase the Consun Pharmaceutical Group Limited report to view the information.

Website: http://www.chinaconsun.com

Basic Information
Total Employees:
Purchase the Consun Pharmaceutical Group Limited report to view the information.
Outstanding Shares:
Purchase the Consun Pharmaceutical Group Limited report to view the information.
Registered Capital:
Purchase the Consun Pharmaceutical Group Limited report to view the information.
Financial Auditors:
Purchase the Consun Pharmaceutical Group Limited report to view the information.
Incorporation Date:
2010
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
24.45%
Purchase this report to view the information.
15.91%
Purchase this report to view the information.
13.64%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Brilliant Reach Group Limited (United Kingdom)
100%
Immense Value Holdings Limited (United Kingdom)
100%
Company Performance
Financial values in the chart are available after Consun Pharmaceutical Group Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
12.7%
Total operating revenue
13.23%
Operating profit (EBIT)
8.77%
EBITDA
7.79%
Net Profit (Loss) for the Period
17.65%
Total assets
15.68%
Total equity
17.56%
Operating Profit Margin (ROS)
-1.1%
Net Profit Margin
1.31%
Return on Equity (ROE)
0.01%
Debt to Equity Ratio
-0.69%
Quick Ratio
0.26%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?